» Articles » PMID: 9792149

Superoxide Dismutases in Relation to the Overall Survival of Colorectal Cancer Patients

Overview
Journal Br J Cancer
Specialty Oncology
Date 1998 Oct 29
PMID 9792149
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Reactive oxygen metabolites are implicated in the initiation and promotion of cancer. In addition, oxidant scavengers, such as manganese--(Mn-SOD) and copper/zinc--superoxide dismutase (Cu/Zn-SOD), are thought to contribute to colorectal cancer treatment response. In the present study, the prognostic significance of the Mn- and Cu/Zn-SOD antigen content of normal mucosa and carcinomas of 163 patients with colorectal cancer was evaluated in comparison with major clinicopathological parameters, with respect to the 5-year overall survival. The Mn-SOD content of carcinomas was found to be significantly higher than that of normal mucosa, whereas there was no difference in the Cu/Zn-SOD content between the normal mucosa and carcinomas. No association was demonstrable between the Mn-SOD and Cu/Zn-SOD content of the tissues and the assessed clinicopathological parameters (gender, age, localization, differentiation grade, diameter and Dukes' stage), with the exception of the Cu/Zn-SOD and the differentiation grade of the carcinomas. Univariate analysis showed that a high Mn-SOD content of carcinomas was associated with a poor 5-year overall survival of the patients with colorectal cancer. Multivariate analysis including all clinicopathological parameters revealed that this Mn-SOD parameter was prognostically independent. The Mn- and Cu/Zn-SOD content of normal mucosa and the Cu/Zn-SOD content of carcinomas were not associated with the overall survival of the patients. In conclusion, this study demonstrates that for patients with colorectal cancer the Mn-SOD content of colorectal carcinomas has a significant prognostic value that is independent from major clinicopathological parameters, including Dukes' stage.

Citing Articles

Gender Differences in Oxidative Stress in Relation to Cancer Susceptibility and Survival.

Allegra A, Caserta S, Genovese S, Pioggia G, Gangemi S Antioxidants (Basel). 2023; 12(6).

PMID: 37371985 PMC: 10295142. DOI: 10.3390/antiox12061255.


Role of Stress-Survival Pathways and Transcriptomic Alterations in Progression of Colorectal Cancer: A Health Disparities Perspective.

Basnet U, Patil A, Kulkarni A, Roy S Int J Environ Res Public Health. 2021; 18(11).

PMID: 34063993 PMC: 8196775. DOI: 10.3390/ijerph18115525.


Metabolic Regulation of Redox Balance in Cancer.

Purohit V, Simeone D, Lyssiotis C Cancers (Basel). 2019; 11(7).

PMID: 31288436 PMC: 6678865. DOI: 10.3390/cancers11070955.


Manganese-enhanced MRI for the detection of metastatic potential in colorectal cancer.

Wen L, Shi X, He L, Lu Y, Han D Eur Radiol Exp. 2018; 1(1):21.

PMID: 29708197 PMC: 5909354. DOI: 10.1186/s41747-017-0024-3.


Manganese-superoxide dismutase (Mn-SOD) overexpression is a common event in colorectal cancers with mitochondrial microsatellite instability.

Govatati S, Malempati S, Saradamma B, Divyamaanasa D, Naidu B, Bramhachari P Tumour Biol. 2016; 37(8):10357-64.

PMID: 26846100 DOI: 10.1007/s13277-016-4918-0.


References
1.
Gotz J, van Kan C, Verspaget H, Biemond I, Lamers C, Veenendaal R . Gastric mucosal superoxide dismutases in Helicobacter pylori infection. Gut. 1996; 38(4):502-6. PMC: 1383104. DOI: 10.1136/gut.38.4.502. View

2.
Beyer W, Imlay J, Fridovich I . Superoxide dismutases. Prog Nucleic Acid Res Mol Biol. 1991; 40:221-53. DOI: 10.1016/s0079-6603(08)60843-0. View

3.
Oberley T, Oberley L . Antioxidant enzyme levels in cancer. Histol Histopathol. 1997; 12(2):525-35. View

4.
LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

5.
ASTLER V, COLLER F . The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg. 1954; 139(6):846-52. PMC: 1609522. DOI: 10.1097/00000658-195406000-00015. View